Drugs · Entity Annotation Prototype (beta)

2articles mentioning drugs

5drug mentions

1distinct drugs extracted

0%of mentions human-reviewed

Active filtersEntity: mirvetuximab soravtansine ×

mirvetuximab soravtansine

This drug is selected. Its supporting articles are shown below.

mirvetuximab soravtansine2

Articles mentioning mirvetuximab soravtansine

2 articles · page 1 of 1

995 MC003: ADoTope, a first-in-class dual-payload bi-epitope combination chemoimmunotherapy antibody drug conjugate (ADC) targeting folate receptor alpha in platinum-resistant epithelial ovarian cancer

jitc · abstract · 2025-11-04 · 4 matching annotations

99.4%

mirvetuximab soravtansine gemcitabine exatecan Clone 65 FDA platinum-resistant ovarian cancer recurrent disease epithelial ovarian cancers Sanyou Biopharmaceuticals Laboratory Animal Ethics Committee SKOV3

…sis, achieved superior tumor growth inhibition and outperformed mirvetuximab soravtansine. Our data highlights the therapeutic potential and tolerability…

New frontiers in the management of recurrent epithelial ovarian cancer: a comprehensive review

gocm · abstract · 2025-12-14 · 1 matching annotations

96.0%

Bevacizumab Trastuzumab deruxtecan adavosertib mirvetuximab soravtansine ovarian cancer HER2-expressing disease PROC platinum-based therapy hyperthermic intraperitoneal chemotherapy